SEC
SlamSEC
Search
Browse
Earnings
Lucid Diagnostics Inc.
Nasdaq:
LUCD
Surgical & Medical Instruments & Apparatus
·
NEW YORK, NY
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Lucid Diagnostics Inc. — SlamSEC
CEO
Aklog Lishan
Revenue
$2.4M
+544.0% YoY
FY 2024
Adj. EBITDA
-$46.0M
-1893.9% margin
FY 2024
Net Income
-$52.7M
-2169.1% margin
FY 2024
EPS (Diluted)
-$1.26
FY 2024
Stock Price
$1.40
-0.4%
2026-03-06
52W Range
$0.95 – $1.80
P/E Ratio
-1.1x
Market Cap
$192.5M
Cash
$18.9M
FY 2024
Total Debt
—
Net Cash
$18.9M
FY 2024
Enterprise Value
$173.6M
Debt / EBITDA
0.4x
FY 2024
EV / EBITDA
-3.8x
Employees
—